Nov 6, 2025 Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
Nov 14, 2024 Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
